Pinestone Capital Limited Overview
Pinestone Capital is a micro-cap Hong Kong securities house whose economics rest on a small book of high-yield, securities-backed credit rather than on brokerage scale. In FY2025, interest from margin financing and money lending supplied 53% of revenue. Bond and equity placing supplied 43%. Retail brokerage commissions contributed barely 4%. The firm serves a concentrated clientele: 201 active securities accounts at end-2025 and 235 by mid-2026. It lends at fixed rates of 12%–34.8% against listed shares, unlisted shares and property.
Between 2021 and 2025 it lost a cumulative HK$119.8m (calc.), driven by HK$138.9m of credit impairments and write-offs (calc.). It survived through five dilutive equity raises, two 20-for-1 share consolidations and repeated board turnover.
Since mid-2025 a new controlling group has repositioned the company. It is pursuing virtual-asset dealing, Type 4/9 advisory and asset management, PRC distressed-asset disposal, and AI-compute partnerships. The company returned to a small profit in 1H2026. Its share price now values it at several times book.
Company's own description
The Group consistently describes itself in its filings as principally engaged in four activities:
-
securities brokerage services;
-
securities-backed lending services, including margin financing and money lending;
-
other (non-securities) secured lending services;
-
placing and underwriting services.
The FY25 RA and 1H26 IA both state that the Group has a single reportable operating segment, managed on an aggregated basis. They also state that all revenue is derived from activities in Hong Kong.
Management has described the lending business as its "core revenue generator" (1H26 IA, Business Review). The Group also says there has been no significant change in its business operations since listing by way of placing (1H26 IA).
Independent characterisation
Functionally, Pinestone is a specialty lender wrapped in a broker-dealer licence. Its brokerage arm is too small to be a profit centre: FY2025 brokerage transaction value was HK$870.3m, generating HK$955k of commission. The arm's main purpose is to:
-
house margin accounts (credit is extended against client portfolios held in custody);
-
provide the regulated platform for placing and underwriting mandates;
-
serve as the base licence for a planned virtual-asset dealing upgrade.
The money-lending subsidiary, Pinestone Capital Group Limited (PCGL), holds a Money Lenders Ordinance (Cap. 163) licence. Through it the Group lends to a handful of corporate and individual borrowers. At 31 Dec 2025 there were five loans, ranging from HK$3.0m to HK$16.5m (FY25 RA).
Business model and revenue model
| Revenue type (FY2025) | HKD K | % of revenue | Nature | Recognition |
|---|---|---|---|---|
| Interest — margin financing | 8,141 | 28.6 | Interest spread on client margin loans; funded from equity, no bank debt | Revenue from other sources |
| Interest — money lending | 6,903 | 24.3 | Term loans at 12%–34.8% fixed | Revenue from other sources |
| Agency fees — bond placing | 7,887 | 27.7 | Fees as placing agent / joint bookrunner, mainly PRC municipal and LGFV bonds | HKFRS 15, point in time |
| Fee income — securities placing/underwriting | 4,369 | 15.4 | Best-efforts placing for HK-listed issuers | HKFRS 15, point in time |
| Brokerage commission | 955 | 3.4 | Transaction-based | HKFRS 15, point in time |
| Handling fees | 180 | 0.6 | Transaction / custody handling | HKFRS 15, point in time |
| Total | 28,435 | 100.0 | — | FY25 RA, Note 5 |
Mix by revenue character (calc.). In FY2025, 52.9% of revenue was interest-based (credit-driven) and 47.1% was transaction or fee-based. Pinestone has no subscription, licensing or product revenue.
Funding model. The Group has no bank borrowings (FY25 RA, Capital Structure). The loan book is funded almost entirely from shareholders' equity raised through rights issues and placings. That is why every raise since 2022 has earmarked proceeds for margin and money lending.
Value-chain position, customers and end-markets
Value-chain position: Pinestone is a small, independent intermediary between Hong Kong / PRC issuers and investors. It is not a clearing member of scale and not a prime broker. It sits at the low-capital, relationship-driven end of the HK broker spectrum.
Customer types: These include high-net-worth individuals, investors and traders, substantial shareholders of HK-listed companies, private-company shareholders, corporate borrowers (property holding and transport businesses), listed issuers seeking placements, and PRC bond issuers (FY25 RA, Table 1 and Note 1).
Customer concentration: The five largest customers accounted for 35% of FY2025 revenue (47% in FY2024). The single largest accounted for 10% (11% in FY2024) (FY25 RA, Major Customers). The five largest borrowers accounted for 67% of total trade and loan receivables at 31 Dec 2025 (FY25 RA).
End-markets: These are the Hong Kong secondary equity market, the Hong Kong equity primary and secondary placing market, the offshore market for PRC local-government and LGFV bonds, and the Hong Kong private secured-credit market.
Strategy
Stated strategic themes (paraphrased from the FY25 RA and 1H26 IA)
-
Balance risk and return in lending. Manage the lending portfolios conservatively, deploying fresh equity into margin financing and money lending while tightening collateral and credit checks.
-
Diversify the service mix into adjacent regulated activities: virtual-asset dealing, Type 4 advisory and Type 9 asset management.
-
Enter PRC distressed assets and receivables collection through acquisition (Jumbo), and build a Hong Kong-based distressed-asset auction platform serving law firms, banks and securities firms.
-
Explore AI-compute investment with Shanghai Fuquan under a "technology + capital + industry" closed-loop concept. Use AI tools internally to cut costs and risk.
-
Maintain cost discipline around professional, compliance, agency and staff costs.
-
Adopt a cautious, conservative posture given geopolitical and rates uncertainty, while positioning for a Hong Kong IPO and placing upcycle.
Initiative register (last 24 months)
| Initiative | Announced | Targets / resources | Status at Oct 2026 | Source |
|---|---|---|---|---|
| Placing of 81.21m shares at HK$0.176 | 18 Dec 2024 | HK$13.86m net for working capital | Completed 13 Jan 2025; fully used by 30 Jun 2025 | FY25 RA |
| Share consolidation (20:1) + 3-for-2 rights at HK$1.66 | 10 Jun 2025 | HK$35.0m margin; HK$15.0m money lending; HK$5.3m VA licence; HK$2.3m working capital | Completed Oct 2025; HK$5.1m (VA) unused at 30 Jun 2026 | FY25 RA; 1H26 IA |
| Remedial internal-control programme after Capital Realm | Apr 2025 onwards | Not quantified | Progress update published 21 Jan 2026 | FY25 RA; etnet announcement list |
| Jumbo Company acquisition (distressed assets) | 30 Sep 2025 | HK$40m via 13,986,014 shares at HK$2.86 (22.96% of the then-enlarged capital) | Not evidenced as completed | Major transaction announcement (Sep 2025) |
| Rename to DODO Asset Holdings | c. 30 Oct 2025 | — | Pending | Change of name announcement; HKEX trading arrangements list |
| Digital-asset JV (40%) | 2,025 | HK$10m | Operating; small losses | FY25 RA |
| Type 1 VA uplift | 2025–2026 | HK$5.3m plus a share of HK$15.65m | Business-plan amendment being finalised | 1H26 IA |
| Type 4 / Type 9 advisory and asset management (LPF fund structures) | 2023 onwards (Type 9 application targeted early 2024) | — | Structuring; licence status unconfirmed | FY23 RA; 1H26 IA |
| Shanghai Fuquan AI-compute cooperation | 28 Jul 2026 | — | Non-binding talks | Voluntary announcement, 28 Jul 2026 |
| General-mandate placing at HK$5.22 | 29 Jul 2026 | HK$15.65m margin (40%); HK$3.90m lending (10%); HK$15.65m VA licence + AI (40%); HK$3.90m working capital (10%). Deployment by Jun–Dec 2027 | Completed 25 Aug 2026 (7.89m of 12.18m shares placed) | 1H26 IA |
| Cost-control programme | Ongoing | Other opex down from HK$16.1m to HK$3.6m (1H25 → 1H26) | Delivered in 1H2026 | 1H26 IA |
ESG / sustainability commitments. None quantified in the sources reviewed.
Medium-term financial targets / guidance. Not publicly disclosed. The company issues only Listing Rules-mandated profit alerts and warnings, for example the 20 Aug 2026 alert guiding to a 1H2026 profit of HK$2.0–3.0m.
Products & Services
Pinestone has no branded products in the consumer sense. Each disclosed offering is listed below.
Securities Brokerage Services (Pinestone Securities Limited)
| Attribute | Detail |
|---|---|
| Description | Dealing in Hong Kong-listed securities for cash and margin clients; settlement on T+2 via HKSCC |
| Capabilities | Mobile securities trading application (launched 2023) and upgraded trading system (FY23 RA). 235 active accounts at 30 Jun 2026; 201 at end-2025; 149 at end-2024 |
| Activity | Transaction value: HK$247.6m (FY2021), HK$89.7m (FY2022), HK$682.3m (FY2023), HK$379.3m (FY2024), HK$870.3m (FY2025) |
| Target customer | HNWIs, active traders, corporate investors |
| Pricing | Commission and handling fees; schedule not publicly disclosed |
| Flagship | None named |
| Planned upgrade | Uplift of the Type 1 licence to include virtual-asset dealing via omnibus or executing-broker arrangements with SFC-licensed VATPs. A business-plan amendment is being finalised for submission to the SFC (1H26 IA). Budget: HK$5.3m from the 2025 rights issue (HK$5.1m unused at 30 Jun 2026), plus a share of HK$15.65m from the 2026 placing |
Margin Financing
| Attribute | Detail |
|---|---|
| Description | Revolving credit secured on pledged listed securities. Facility size is set by the discounted market value of collateral. Trade receivables have no fixed repayment term |
| Key terms | Fixed rates of 12%–23% p.a. at 31 Dec 2025 (8%–24% in 2024). MD&A cites a range of 8%–35% across related receivables (FY25 RA) |
| Book size | Gross margin receivables: HK$100.7m (2021), HK$90.8m (2022), HK$156.8m (2023), HK$76.8m (2024), HK$102.2m (2025), HK$131.3m (30 Jun 2026). The average monthly book in 1H2026 was HK$133.9m against HK$74.0m in 1H2025 |
| Risk controls | Margin calls; forced liquidation; instalment repayment schedules; ECL staging. In 2025 four clients were placed at Stage 2 (15% provision) and one at Stage 3 (100%) |
| Target customer | Individual and corporate investors |
| Growth funding | HK$35.0m (2025 rights; HK$50.0m actually deployed to lending lines) plus HK$15.65m (2026 placing) |
Money Lending and Other Secured Lending (PCGL)
| Attribute | Detail |
|---|---|
| Description | Term loans, usually up to 12 months with extensions. Secured on listed or unlisted share charges, property, or third-party guarantees |
| Key terms | Fixed rates of 12.0%–34.8% p.a. (FY25 RA; 1H26 IA) |
| Book size | Gross: HK$67.8m (2021), HK$111.4m (2022), HK$100.2m (2023), HK$74.4m (2024), HK$48.7m (2025), HK$29.7m (30 Jun 2026) |
| Loan count | 8 loans (end-2024) → 5 (end-2025) → 3 (mid-2026). Two loans were redeemed in 1Q2026 |
| Largest exposures (31 Dec 2025) | (1) Individual CEO borrower, HK$21.1m book, Stage 3; (2) property-holding company, HK$16.9m, HK$16.5m principal at 12%, extended to Jan 2027, secured on property valued at about HK$238m; (3) individual merchant, HK$3.7m, 100% impaired; (4) transport company, HK$3.8m; (5) private-company shareholder, HK$3.2m at 34.8% |
| Target customer | Investors, HNWIs, substantial shareholders of HK-listed companies, corporates with pledgeable assets |
| Funding | Equity only; HK$15.0m from the 2025 rights issue plus HK$3.9m from the 2026 placing |
Placing and Underwriting Services
| Attribute | Detail |
|---|---|
| Description | Best-efforts placing agent, sub-underwriter and joint bookrunner for HK-listed issuers' equity placings and for offshore PRC bond issues, including municipal bonds |
| Activity | 0 deals with revenue in 2022; HK$87k in 2023; 14 mandates (2024); 21 (2025); 5 (1H2026) |
| Historical focus | Small-cap IPOs, including GEM (FY22 RA) |
| Pricing | Percentage fees and agency fees; rates not publicly disclosed |
| Outlook | Talks with several listed issuers on underwriting corporate actions in 2H2026 (1H26 IA) |
Advisory Services
Advisory fees of HK$338k were recognised in FY2024; none were recognised in FY2025. Contract liabilities for advisory deposits were HK$355k at end-2025 and nil at 30 Jun 2026 (FY25 RA; 1H26 IA). The Group is pursuing a Type 4 (advising on securities) business aimed at family offices and HNWIs; whether the licence has been granted is not confirmed in the sources reviewed.
Pipeline / Announced New Businesses (not yet revenue-generating)
| Initiative | Status | Disclosed resources | Source |
|---|---|---|---|
| Asset management (SFC Type 9) via HK Limited Partnership Fund and offshore fund structures | Structuring and legal/tax work under way; whether the licence has been granted is not confirmed in sources reviewed | — | FY23 RA; 1H26 IA |
| Virtual-asset dealing (Type 1 uplift) | Business plan being finalised for SFC | HK$5.1m unused at 30 Jun 2026, plus part of HK$15.65m | 1H26 IA |
| Distressed-asset disposal and receivables collection (PRC/HK), including an auction platform in Hong Kong | Jumbo acquisition agreed Sep 2025; completion not evidenced | HK$40m in consideration shares | Major transaction announcement (Sep 2025); FY25 RA Outlook |
| AI-compute ecosystem with Shanghai Fuquan Technology | Non-binding talks; subject to a definitive agreement | Shares HK$15.65m with VA licence (2026 placing) | Voluntary announcement, 28 Jul 2026 |
| Digital-asset JV (virtual real estate / DeFi) | 40% associate, HK$10m invested; share of loss HK$109k in FY2025 | HK$10m | FY25 RA; Nasdaq/TipRanks |
Financial Narrative
All figures are audited annual results for FY2021–FY2025, in HK$'000, from FY22 RA, FY23 RA and FY25 RA. Because Pinestone is a financial intermediary, "gross profit" and "EBITDA" are not native concepts. Analyst proxies are defined below each table.
Income Statement — chartable
PPOP is defined as loss before tax plus impairment and write-offs. Other income was boosted in FY2025 (HK$1.79m); the components were not itemised in the RA.
Per-share data (as reported; not comparable across years)
Caution. EPS figures are taken as last reported. FY2021 was restated in the FY22 RA, FY2022 in the FY23 RA, and FY2024 in the FY25 RA. Each restatement reflects a different set of consolidations and rights bonus elements, so the series is not on a consistent share basis. FY2023's -7.08 cents predates the 2025 20:1 consolidation; on a post-2025 basis it would be substantially larger (not reported). 1H2026 basic EPS was +4.28 cents, against a restated loss of -9.91 cents in 1H2025 (1H26 IA).
Margin analysis (calc.)
Revenue CAGR FY2021–FY2025: +3.3% p.a. (calc.).
Commentary.
The five-year P&L tells one story: credit losses overwhelmed a business that was modestly profitable before provisions. Pre-provision profit peaked at HK$7.4m in FY2021, then fell to roughly zero in FY2025. Over the same period cumulative impairments and write-offs reached HK$138.9m (calc.), against cumulative revenue of HK$118.6m (calc.).
FY2022 was the inflection. The collapse in collateral values in January 2022 turned eight margin and term-loan clients into effectively unsecured exposures, leading to a HK$49.6m impairment (FY23 RA).
FY2024 crystallised those losses: HK$16.2m of write-offs were added to HK$20.9m of new impairments.
FY2025 marked the turn in credit, with impairments down 68% to HK$11.7m. However, two cost items absorbed the improvement:
-
Other operating expenses rose 65% to HK$19.4m, which management attributes to compliance, legal and professional costs from two equity raises, the Capital Realm investigation and new-business exploration.
-
A HK$5.8m deferred-tax asset write-down was recognised after reassessing the recoverability of past tax losses.
1H2026 shows that the cost spike was largely non-recurring. Other operating expenses fell to HK$3.6m (from HK$16.1m in 1H2025), and no new impairments were booked. This produced the HK$2.8m profit despite a 22% revenue decline.
Balance Sheet — chartable
The gross gross book is margin plus money-lending receivables before allowance. The HK$500k intangible asset is unchanged throughout and is likely a trading right; its nature is not specified in the RAs reviewed.
30 Jun 2026 snapshot (1H26 IA).
-
Total assets HK$275.5m; equity HK$198.5m.
-
Cash HK$38.2m; trust balances HK$69.8m.
-
Net trade receivables HK$117.2m; net loans receivable HK$22.7m.
-
Lease liabilities HK$1.5m; amount due to an associate HK$3.3m.
The 25 Aug 2026 placing added about HK$39.1m of net equity after the period end. Pro forma equity is therefore about HK$237.6m (calc.).
Short / long-term debt split. There is no bank debt in any year. Lease liabilities at end-2025 were HK$713k current and HK$1,145k non-current (FY25 RA).
Asset-quality indicators — chartable (calc.)
Source for the concentration rows: MD&A of each RA.
Cash Flow
Available data:
Sources: 1H22 IA and 1H26 IA.
Cumulative net equity raised Nov 2022 – Aug 2026: about HK$154.7m (calc.). That compares with cumulative net losses of HK$115.0m over FY2022–FY2025 (calc.).
Ratios — chartable (calc. unless stated)
ROIC: approximates ROE because invested capital is essentially all equity.
Net debt / EBITDA and interest coverage: are not meaningful: the company has net cash, negative EBITDA, and its only finance cost is lease interest (HK$54k in FY2025).
Cash conversion cycle: is not meaningful for a broker-lender.
- The current ratio fell to 3.30x at 30 Jun 2026 because client trust balances and payables swelled (1H26 IA).
Commentary on the balance sheet.
Pinestone is massively over-capitalised relative to its revenue. Equity of about HK$196m supported only HK$28m of revenue in FY2025, and leverage is effectively zero. This is a deliberate funding choice: equity is the only source of lending capital.
The corollary is a structurally low ROE ceiling. Even at FY2021's best-case pre-provision profit of HK$7.4m, pre-tax ROE before credit losses would be under 4%.
The allowance-coverage trend deserves close monitoring. Coverage fell from 47.5% to 14.1% as legacy exposures were written off. The gross book is now cleaner, but HK$24.8m of money-lending receivables and HK$9.5m of margin receivables remained credit-impaired at end-2025 (FY25 RA). Meanwhile the margin book has grown roughly 28% since then, from HK$102.2m to HK$131.3m.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Licence | Source |
|---|---|---|---|
Pinestone Capital Limited (Cayman) | Listed holding company | — | 1H26 IA |
Pinestone Securities Limited | Broker-dealer; custody of margin accounts; placing agent (including for the company's own Jul 2026 placing) | SFC Type 1 (dealing in securities); a Type 4/9 extension is being pursued (status not confirmed) | 1H26 IA |
Pinestone Capital Group Limited (PCGL) | Money lending and other secured lending | Money Lenders Ordinance licence | FY25 RA |
Associate (name not disclosed) | 40% digital-asset JV | — | FY25 RA (investment in associates HK$10m; amount due to associate HK$3.3m) |
Jumbo Company Limited (proposed) | Distressed-asset disposal platform (PRC/HK) | — | Major transaction announcement (Sep 2025). Completion not evidenced: the share count of 68.8m excludes the 13,986,014 consideration shares |
Revenue by Segment
| Service line (HKD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Securities-backed lending interest (HKD K) | 24,181 | 19,240 | 18,697 | 17,749 | 15,044 |
of which Margin financing interest (HKD K) | 15,633 | 11,907 | 9,823 | 11,866 | 8,141 |
of which Money lending interest (HKD K) | 8,548 | 7,333 | 8,874 | 5,883 | 6,903 |
Placing & underwriting incl. bond agency fees (HKD K) | 83 | 0 | 87 | 6,903 | 12,256 |
Brokerage commission + handling fees (HKD K) | 709 | 231 | 1,440 | 510 | 1,135 |
Advisory fees (HKD K) | 0 | 0 | 0 | 338 | 0 |
Total revenue (HKD K) | 24,973 | 19,471 | 20,224 | 25,500 | 28,435 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%) and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Lending share of revenue (%) | 96.8 | 98.8 | 92.4 | 69.6 | 52.9 |
Placing share of revenue (%) | 0.3 | 0.0 | 0.4 | 27.1 | 43.1 |
Brokerage share of revenue (%) | 2.8 | 1.2 | 7.1 | 2.0 | 4.0 |
Lending revenue YoY growth (%) | 0 | -20.4 | -2.8 | -5.1 | -15.2 |
Total revenue YoY growth (%) | 0 | -22.0 | 3.9 | 26.1 | 11.5 |
Revenue by Segment (FY2024–FY2025)
| Placing line (HKD K) | FY2024 | FY2025 |
|---|---|---|
Fee income — securities placing/underwriting (HKD K) | 1,258 | 4,369 |
Agency fees — bond placing (HKD K) | 5,645 | 7,887 |
Number of placing/underwriting mandates | 14 | 21 |
Business Lines
| Line (HKD K) | 1H2025 | 1H2026 | YoY % (calc.) |
|---|---|---|---|
Brokerage commission | 580 | 1,357 | +134 |
Placing & underwriting | 8,927 | 1,676 | -81 |
Handling fees | 49 | 962 | — |
Margin financing interest | 3,213 | 6,916 | +115 |
Money lending interest | 4,105 | 2,280 | -44 |
Total | 16,875 | 13,191 | -22 |
Income Statement
| Metric (HKD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD K) | 24,973 | 19,471 | 20,224 | 25,500 | 28,435 |
Other income (HKD K) | 44 | 88 | 65 | 332 | 1,794 |
Commission and fee expenses (HKD K) | 0 | 0 | -719 | -743 | -1,515 |
Net revenue after commission expense, gross profit proxy (HKD K) | 24,973 | 19,471 | 19,505 | 24,757 | 26,920 |
Employee benefit expenses (HKD K) | -9,309 | -10,107 | -8,911 | -6,950 | -8,588 |
Depreciation (HKD K) | -1,953 | -1,033 | -974 | -619 | -355 |
Other operating expenses (HKD K) | -6,295 | -7,107 | -5,113 | -11,747 | -19,390 |
Impairment losses on trade and loan receivables, net (HKD K) | -12,499 | -49,568 | -28,012 | -20,900 | -9,980 |
Loss from write-off of receivables (HKD K) | 0 | 0 | 0 | -16,153 | -1,769 |
Share of losses of associates (HKD K) | 0 | 0 | 0 | 0 | -109 |
Finance costs, lease interest (HKD K) | -67 | -89 | -49 | -9 | -54 |
Loss before income tax (HKD K) | -5,106 | -48,345 | -23,489 | -31,289 | -11,531 |
Income tax credit or expense (HKD K) | 173 | 6,875 | -899 | -377 | -5,807 |
Net loss (HKD K) | -4,933 | -41,470 | -24,388 | -31,666 | -17,338 |
Pre-provision operating profit (HKD K, calc.) | 7,393 | 1,223 | 4,523 | 5,764 | 218 |
EBITDA proxy: LBT + depreciation + finance costs (HKD K, calc.) | -3,086 | -47,223 | -22,466 | -30,661 | -11,122 |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Basic & diluted EPS, as reported (HK cents) | -2.15 | -16.51 | -7.08 | -106.16 | -43.18 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net revenue after commission / revenue (%) | 100.0 | 100.0 | 96.4 | 97.1 | 94.7 |
PPOP margin (%) | 29.6 | 6.3 | 22.4 | 22.6 | 0.8 |
Pre-tax margin (%) | -20.4 | -248.3 | -116.1 | -122.7 | -40.6 |
Net margin (%) | -19.8 | -213.0 | -120.6 | -124.2 | -61.0 |
Credit cost: impairment + write-off / revenue (%) | 50.0 | 254.6 | 138.5 | 145.3 | 41.3 |
Balance Sheet
| Metric (HKD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD K, calc.) | 199,300 | 169,942 | 176,014 | 154,872 | 208,862 |
Cash and bank balances, own (HKD K) | 45,580 | 30,140 | 23,394 | 15,929 | 41,812 |
Trust bank balances for clients (HKD K) | 2,598 | 3,125 | 3,001 | 12,585 | 7,339 |
Trade receivables, net (HKD K) | 91,007 | 53,187 | 97,822 | 55,134 | 88,217 |
Loans receivable, net (HKD K) | 51,321 | 68,948 | 37,121 | 47,749 | 41,650 |
Gross margin and loan book (HKD K, calc.) | 168,751 | 202,249 | 257,059 | 155,928 | 151,135 |
Total loss allowance (HKD K, calc.) | 26,423 | 80,114 | 122,116 | 53,045 | 21,268 |
Deferred tax assets (HKD K) | 3,905 | 11,453 | 12,677 | 12,284 | 6,477 |
Goodwill and intangibles (HKD K) | 500 | 500 | 500 | 500 | 500 |
Investment in associates (HKD K) | 0 | 0 | 0 | 0 | 10,000 |
Total debt: bank borrowings (HKD K) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities, current + non-current (HKD K) | 2,511 | 1,587 | 622 | 0 | 1,858 |
Net cash: cash less leases (HKD K, calc.) | 43,069 | 28,553 | 22,772 | 15,929 | 39,954 |
Total liabilities (HKD K, calc.) | 7,577 | 5,466 | 5,976 | 16,500 | 13,207 |
Total equity (HKD K) | 191,723 | 164,476 | 170,038 | 138,372 | 195,655 |
Net current assets, working capital (HKD K) | 185,775 | 151,336 | 156,035 | 118,971 | 170,409 |
Margin Analysis (%)
| Metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Loss allowance / gross book (%) | 15.7 | 39.6 | 47.5 | 34.0 | 14.1 |
Impairment + write-off / year-end gross book (%) | 7.4 | 24.5 | 10.9 | 23.8 | 7.8 |
Top-5 borrowers / total trade + loan receivables (%) | 76 | 66 | 58 | 61 | 67 |
Largest borrower / total receivables (%) | 24 | 16 | 16 | 13 | 16 |
Top-5 customers / revenue (%) | 72 | 66 | 49 | 47 | 35 |
Cash Flow
| Item (HKD K) | 1H2021 | 1H2022 | 1H2025 | 1H2026 |
|---|---|---|---|---|
Net cash from / (used in) operating activities | (24,978) | 23,033 | (13,212) | (3,282) |
Net cash from / (used in) investing activities | 0 | 0 | (54) | 59 |
Net cash from / (used in) financing activities | (1,072) | (506) | 14,294 | (398) |
Annual Item Details
| Annual item | FY2021–FY2025 finding | Source |
|---|---|---|
Capex | Minimal. Property, plant and equipment is mainly right-of-use assets. No PPE acquisitions in 1H2025 or 1H2026 | 1H26 IA, Note 11 |
Free cash flow | Not meaningful for a lender, since operating cash flow is dominated by loan-book movements. | — |
Dividends paid | Nil in every year FY2021–FY2025 and in 1H2026 | Each RA |
Share buybacks | None in FY2021–FY2025 or 1H2026 | Each RA |
Equity raised (net) | FY2022 HK$14.22m; FY2023 HK$29.95m; FY2025 HK$13.86m + HK$57.6m; FY2026 (to Aug) HK$39.1m | RAs; 1H26 IA |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on year-end equity (%) | -2.6 | -25.2 | -14.3 | -22.9 | -8.9 |
ROA on year-end assets (%) | -2.5 | -24.4 | -13.9 | -20.4 | -8.3 |
Current ratio, as reported (x) | 32.01 | 32.25 | 27.11 | 8.21 | 15.13 |
Lease debt / equity (x) | 0.013 | 0.010 | 0.004 | 0.000 | 0.009 |
Asset turnover: revenue / total assets (x) | 0.125 | 0.115 | 0.115 | 0.165 | 0.136 |
Equity / total assets (%) | 96.2 | 96.8 | 96.6 | 89.3 | 93.7 |
Region revenue (HKD K)
| Region revenue (HKD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Hong Kong revenue (HKD K) | 24,973 | 19,471 | 20,224 | 25,500 | 28,435 |
Rest of world revenue (HKD K) | 0 | 0 | 0 | 0 | 0 |
Region growth (%)
| Region growth (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Hong Kong YoY growth (%) | 3.9 | 26.1 | 11.5 |
Share Count (number) and Capital Markets Data (HKD)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Shares in issue at year-end (number) | 4,511,890,000 | 270,713,400 | 406,070,100 | 406,070,100 | 60,910,013 |
Par value at year-end (HKD) | 0.001 | 0.02 | 0.02 | 0.02 | 0.40 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Net equity raised (HKD K) | 0 | 14,220 | 29,950 | 0 | 71,460 |
Document Details
| Document | Net proceeds stated |
|---|---|
FY25 RA Note 13(3) | HK$60.5m |
FY25 RA MD&A | HK$59.3m |
FY25 RA use-of-proceeds table; 1H26 IA | HK$57.6m |
Date Completed Details
| Date completed | Type | Shares | Price (HKD) | Net proceeds (HKD Mn) | Stated use |
|---|---|---|---|---|---|
8 Nov 2022 | Placing (general mandate) | 45,118,900 | 0.32 | 14.22 | Expand existing business |
10 Jul 2023 | Rights issue 1-for-2 | 135,356,700 | 0.225 | 29.95 | 50% securities-backed lending; 50% other secured lending |
13 Jan 2025 | Placing (general mandate) | 81,210,000 | 0.176 | 13.86 | Working capital |
Oct 2025 | Rights issue 3-for-2 (after 20:1 consolidation) | 36,546,008 | 1.66 | 57.6 | Margin HK$35.0m; lending HK$15.0m; VA HK$5.3m; working capital HK$2.3m |
25 Aug 2026 | Placing (general mandate); placing agent was the company's own subsidiary | 7,890,000 | 5.22 | 39.1 | Margin 40%; lending 10%; VA licence + AI 40%; working capital 10% |
Share Price History
| Date | Price (HKD) | Note | Source |
|---|---|---|---|
10 Jun 2025 | 0.140 pre-consolidation (≈ 2.80 post-consolidation equivalent) | Last trading day before the rights proposal | FY25 RA |
Oct 2025 | 1.66 | Rights subscription price; theoretical ex-rights price 2.132 | FY25 RA |
16–17 Jun 2026 | 3.52 / 3.40 | 52-week range then 1.327–5.61 | Morningstar; Investing.com |
6 Jul 2026 | 3.69 | — | etnet |
29 Jul 2026 | 6.52 close | Placing date; 5-day average 3.77 | 1H26 IA |
Late Jul / Aug 2026 | 8.40 | — | etnet |
16 Sep 2026 | 14.12 close | — | Sohu/Securities Star |
23 Sep 2026 | 16.52 intraday | Up 10% on the day after interim results | Caiwen News |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation | ≈ HK$1,137m | 68.8m × HK$16.52 |
P/B | ≈ 4.8x | Pro forma equity of about HK$237.6m (HK$198.5m at 30 Jun 2026 plus HK$39.1m placing) |
EV | ≈ HK$1,059m | Market cap less pro forma own cash of about HK$77.3m |
EV/Sales (TTM) | ≈ 43x | TTM revenue of about HK$24.8m |
Morningstar fair value estimate | HK$2.94 (13 Jun 2026) | Third-party quantitative estimate |
Capital Markets
| Item | Finding | Source |
|---|---|---|
Analyst consensus | None. No sell-side coverage identified | — |
Dividend policy | No dividend paid FY2021–FY2025 or in 1H2026; no stated policy | Each RA; 1H26 IA |
Buyback authorisation | General repurchase mandate (up to 10%) renewed at each AGM. No buybacks executed FY2021 to 1H2026 | AGM circulars; RAs |
Credit ratings (Moody's / S&P / Fitch) | None; unrated | — |
Debt maturity profile | No borrowings. Lease liabilities of HK$1.5m run to about 2028 (not specified) | 1H26 IA |
Public float | Company confirmed a 25% public float under Rule 8.08 at the FY25 RA date | FY25 RA |
Analyst Conclusions
Management guidance
No quantitative guidance is given. Management's qualitative outlook for 2H2026 (1H26 IA) has four elements:
-
a mild Hong Kong market recovery is expected;
-
brokerage should continue to benefit from IPO-driven turnover;
-
borrower demand for lending is expected to increase;
-
placing and underwriting demand should rise in 2H2026.
Management also commits to a cautious, conservative posture and continued cost control. Placing proceeds are scheduled for deployment by June–December 2027.
Consensus
No consensus estimates exist.
Bull case
-
The credit cycle has turned and new capital earns high yields. No impairments in 1H2026, an 81% larger average margin book and about HK$58m of fresh lending capital since 2025 could plausibly lift annualised interest income towards HK$20m+. The core cost base is now about HK$10m per half (1H26 IA).
-
Optionality from licence upgrades. VA dealing, Type 4 advisory and Type 9 asset management would turn a sub-scale broker into a multi-licence platform at a time when Hong Kong is promoting both virtual assets and family offices.
-
Distressed assets and AI-compute could reshape the earnings mix. The Jumbo platform and the Fuquan cooperation target large addressable markets. A new controlling group (Lu Weixing) with a fresh brand (DODO) signals a real strategic change rather than drift.
Bear case
-
The core business has never earned its cost of capital. Five consecutive annual losses totalled HK$119.8m. FY2025 pre-provision profit was just HK$0.2m. The 1H2026 profit depended on the absence of provisions and on non-recurring cost relief.
-
Concentrated, high-yield lending invites adverse selection. Five borrowers hold 67% of receivables. Loans priced up to 34.8% and a history of collateral collapse make the risk of another cycle high.
-
Valuation has detached from fundamentals. At about 4.8x book and about 43x TTM sales, the shares price in success across several unproven pivots. Meanwhile governance has been unstable (CEO vacancy, mass resignations, a connected-loan breach), custody is concentrated and more dilution looks likely.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Why it matters |
|---|---|
| Effective date of the DODO rename | Confirms the strategic repositioning |
| Completion or lapse of the Jumbo acquisition | Adds about 20% dilution; first test of the distressed-asset strategy |
| SFC approval of the VA uplift and Type 4/9 licences | Gates the new revenue lines |
| Definitive agreement with Shanghai Fuquan, or its abandonment | Credibility of the AI-compute narrative |
| CEO appointment and board stability | Governance credibility |
| FY2026 results (expected Mar 2027): impairment line and PPOP | Tests whether the turnaround is sustainable |
| Margin-book quality as it grows past HK$131m | Credit-risk build-up |
| Further equity raises at elevated prices | Dilution vs. balance-sheet strengthening |
| PRC bond-issuance policy | Possible return of agency fees |
| CCASS concentration and trading liquidity | Price-discovery risk |
Concluding Analyst Verdict
Pinestone Capital is best understood as a lightly-levered, equity-funded specialty lender with a broker-dealer licence attached. It is now being used as a vehicle for a series of thematic pivots: virtual assets, PRC distressed assets and AI compute.
The historical record is unambiguous. From FY2021 to FY2025 the company produced HK$118.6m of revenue and HK$119.8m of cumulative net losses. Credit impairments and write-offs of HK$138.9m exceeded total revenue. The losses stemmed from a concentrated book of securities-backed loans whose collateral failed in 2022.
Survival has depended on shareholders. About HK$155m of net equity was raised across five transactions, alongside two 20-for-1 consolidations.
The 1H2026 profit of HK$2.8m is genuine but narrow. It reflects a period with no new provisions, the reversal of FY2025's one-off professional costs and a doubling of margin interest during a hot IPO market. Placing revenue, the FY2025 growth engine, fell by four-fifths as PRC bond issuance dried up. Pre-provision earnings power is probably in the HK$5–15m range annually on the current capital base. That supports an ROE in the low single digits at best.
Against this, the market capitalisation of roughly HK$1.1bn implies investors are paying almost entirely for unexecuted strategy. None of the following is yet achieved:
-
the Jumbo acquisition has not been evidenced as complete a year after signing;
-
the VA and Type 9 licences have not been confirmed;
-
the AI partnership is non-binding;
-
the rename is pending;
-
the CEO seat is empty.
Governance lapses in 2025 and the June 2026 board exodus argue for a meaningful discount, not a premium.
Verdict. The fundamental case is weak and the valuation is speculative. On the evidence in filings, a cautious stance is warranted until two things happen. First, at least one new licence or acquisition is closed and contributes revenue. Second, a full year passes without material credit impairment.
Investors should treat the shares as a high-risk special situation. Dilution, governance and liquidity risk dominate.
Prepared from public sources only: HKEX filings (final results FY2021–FY2025; interim results 1H2022–1H2026; corporate announcements 2015–2026) and secondary aggregators (etnet, lixinger, TipRanks, MT Newswires, Gelonghui, Caiwen, Sohu/Securities Star, Morningstar, Investing.com). Figures are not investment advice; the author is not a licensed financial adviser.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / tenure | Background (as disclosed) | Source |
|---|---|---|---|---|
Lee Chun Tung (李鎮彤) | Executive Director; Co-Chairman | Long-serving ED; CEO c. 2022–2024; chairman 2 Jun 2025; co-chairman since 23 Oct 2025 | — | FY22 RA; FY23 RA; Annual Report 2025 |
Cheung Ka Yi (張嘉儀) | Executive Director | 2 Jun 2025 | — | Annual Report 2025 |
Lu Weixing (陸偉星) | Non-executive Director; Co-Chairman | 23 Oct 2025 | Sole owner of Group Target Limited (9.46% at 30 Jun 2026) | 1H26 IA |
Wang Han (王涵) | Non-executive Director | ED and CEO 2 Jun 2025; stepped down as CEO and redesignated NED 30 Jun 2026 | Regional director for Guangdong at Alibaba Auction (Taobao China), May 2020 – Sep 2022; appointed to lead distressed-asset strategy | Jumbo announcement coverage (Oct 2025); 1H26 IA |
Lau Kelly (劉基力) | INED; audit committee member | Long-serving (on board by 2022) | — | FY22 RA; 1H26 IA |
Wong Chun Peng Stewart (黃俊鵬) | INED; audit committee member | Long-serving (on board by 2022) | — | FY22 RA; 1H26 IA |
Wong Chun Yip Gavin | INED; Audit Committee Chairman | 10 Aug 2026 | Fellow of the HKICPA | 1H26 IA |
Governance Overview
| Item | Status | Source |
|---|---|---|
Size | 7 directors: 2 executive, 2 non-executive, 3 independent | 1H26 IA |
Independence | 3 of 7 (42.9%), above the Listing Rules one-third minimum | Calc. |
Gender | 1 of 7 directors is female (Cheung Ka Yi) | Calc. |
Chair / CEO separation | Co-chairmen Lee Chun Tung and Lu Weixing; CEO post apparently vacant since 30 Jun 2026 | 1H26 IA |
Audit committee | 3 INEDs, chaired by Wong Chun Yip Gavin from 10 Aug 2026. Previously chaired by Cheng Man Pan (FCCA), who resigned 30 Jun 2026 | 1H26 IA; FY25 RA |
Independent Board Committee | Established 10 Jun 2025 for the rights issue | MarketScreener news log |
Listing Rules compliance | Temporary non-compliance disclosed 30 Jun 2026 after four resignations; apparently remedied by the 10 Aug 2026 appointment | Board-change announcement, 30 Jun 2026; 1H26 IA |
Board & Management Changes
| Date | Change |
|---|---|
10 Jan 2025 | Li Dapeng resigned as Vice-Chairman and ED |
26 Feb 2025 | Shi Zhu appointed Co-Chairman and NED; Zhu Zheping redesignated Co-Chairman |
9 Apr 2025 | Shi Zhu's duties suspended pending investigation (Capital Realm connected-loan matter) |
17 Apr 2025 | Choi Pun Lap removed as joint company secretary |
30 May 2025 | Zhu Zheping and Shi Zhu retired; Liu Yundi resigned |
2 Jun 2025 | Lee Chun Tung appointed Chairman; Wang Han (ED and CEO) and Cheung Ka Yi (ED) appointed |
23 Oct 2025 | Lu Weixing (Co-Chairman, NED), Lu Lin (NED) and Jiang Tiancui (INED) appointed; Lee Chun Tung redesignated Co-Chairman |
30 Jun 2026 | Lau Chun Hung (NED), Lu Lin (NED), Cheng Man Pan (INED) and Jiang Tiancui (INED) resigned; Wang Han redesignated NED and ceased as CEO |
10 Aug 2026 | Wong Chun Yip Gavin appointed INED and Audit Committee Chairman |
Directors' Remuneration
| Item | 1H2025 | 1H2026 | Source |
|---|---|---|---|
Salaries, allowances and benefits — directors and senior management (HKD K) | 2,451 | 4,734 | 1H26 IA, Note 19 |
Retirement contributions (HKD K) | 44 | 168 | Same |
Total as reported (HKD K) | 2,495 | 5,772 | Same |
Major Shareholders
| Holder | Shares | % of 60,910,013 (30 Jun 2026) | % of 68,800,013 post-placing (calc.) | Source |
|---|---|---|---|---|
Group Target Limited (Lu Weixing) | 5,760,000 | 9.46 | 8.37 | 1H26 IA |
Ultimate Vantage Group Limited (Zeng Wenling, since 25 Apr 2025) | 4,841,813 | 7.95 | 7.04 | 1H26 IA |
Other directors' interests | Not disclosed as material | — | — | 1H26 IA |
Shareholding by CCASS Participant
| CCASS participant | % of shares |
|---|---|
Yuanku Securities (元庫證券) | 38.48 |
Pinestone Securities (the company's own broker) | 36.02 |
Futu Securities | 8.04 |
Huasheng Capital | 4.95 |
Interactive Brokers HK | 1.20 |
HSBC | 0.74 |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Relative positioning of Pinestone |
|---|---|---|
Retail and online brokerage | Futu Holdings (Futu Securities); UP Fintech (Tiger Brokers); Bright Smart Securities & Commodities (HKEX 1428) | Sub-scale. FY2025 brokerage commission was HK$0.96m. No pricing or technology advantage |
Small and mid-cap brokerage / margin lending | Emperor Capital Group (717); Get Nice Holdings (64); First Shanghai Investments (227); Cinda International (111); Sunwah Kingsway (188) | Comparable model but far smaller book; higher-yield, more concentrated lending |
Placing / underwriting (small caps, PRC bonds) | PRC-affiliated HK brokers, e.g. Guotai Junan International (1788, now part of the Guotai Haitong group) and other mainland-backed houses; boutique placing agents | Niche participant, relationship-driven; bond-placing access appears opportunistic |
Private secured lending | HK licensed money lenders; specialty finance arms of small brokers | Lends at 12%–34.8% to borrowers banks will not serve; adverse-selection risk |
Virtual-asset dealing (planned) | Brokers already uplifted for VA dealing (e.g. Futu, Tiger, Victory Securities (8540)); SFC-licensed VATPs such as HashKey Exchange and OSL | Late entrant; licence not yet obtained |
Distressed assets (planned) | PRC AMCs and their HK arms; online judicial-auction platforms (e.g. Alibaba Auction, where Wang Han previously worked) | No track record; depends on completing the Jumbo deal |
Competitor Detail
| Metric | Pinestone (FY2025) |
|---|---|
Revenue | HK$28.4m |
Revenue growth (YoY) | +11.5% |
Net margin | -61.0% |
Leverage (bank debt / equity) | 0.0x |



